A single dose of a pharmaceutical formulation of LSD provides significant relief for patients with moderate-to-severe generalized anxiety disorder (GAD).

For life after TBI, nurse practitioners are in a pivotal position to identify post-traumatic headache for veterans early.

Providing timely pain relief may reduce chances of hospitalization for children presenting to the emergency department with a sickle cell crisis.

The FDA has accepted for review the BLA for nanoencapsulated sirolimus plus pegadricase in the treatment of uncontrolled gout.

Experts weigh in on the use of real-world evidence (RWE) in pain research, providing recommendations for rigorous study design, analysis, and reporting to ensure data validity and credibility.

More than half of severely injured trauma patients first treated at level III or nontrauma centers are not transferred to higher-level trauma centers.

The US Food and Drug Administration released draft guidance to advance safe and effective nonopioid treatment options and reduce risks tied to prescription opioid misuse.

Chagas disease — a potentially serious illness spread by an insect called the “kissing bug” — may be establishing itself in ...

Soft water exposure may increase the risk of developing RA, especially among genetically predisposed individuals.

For African American patients undergoing mastectomy, the risk for complications and additional surgeries are the top concerns driving breast reconstruction decisions.

Loneliness, hopelessness, and feelings of worthlessness and failure are key factors driving suicidal feelings in adults with autism.

Among patients with GCA, those with low vs high CRP levels more often presented with anterior ischemic optic neuropathy and limb claudication.